MARAGANORE JOHN

CIK 000118043210 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001180432

Recent Transactions

50 trades

Disposition to Issuer
TAKEDA PHARMACEUTICAL CO LTD$TAK
Tax Obligation Award
2026-07-10$4931.20/sh−1,152→ 0 total
Award
TAKEDA PHARMACEUTICAL CO LTD$TAK
Tax Obligation Award
2026-07-01+1,319→ 1,319 total
Award
TAKEDA PHARMACEUTICAL CO LTD$TAK
Ordinary Shares
2026-07-01+3,800→ 10,400 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-06-24+6,068→ 6,068 total
Award
Rapport Therapeutics, Inc.$RAPP
Stock Option (Right to Buy)
2026-06-10+15,200→ 15,200 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2026-06-03+19,676→ 19,676 total
Conversion
Hemab Therapeutics Holdings, Inc.$COAG
Common Stock
2026-05-04+17,974→ 35,948 total
Conversion
Hemab Therapeutics Holdings, Inc.$COAG
Series C Preferred Stock
2026-05-04−817→ 0 total
Conversion
Hemab Therapeutics Holdings, Inc.$COAG
Series B Preferred Stock
2026-05-04−817→ 0 total
Conversion
Hemab Therapeutics Holdings, Inc.$COAG
Common Stock
2026-05-04+17,974→ 17,974 total
Award
Hemab Therapeutics Holdings, Inc.$COAG
Warrants (Right to Buy)
2026-01-29+107,338→ 107,338 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 total
Award
Rapport Therapeutics, Inc.$RAPP
Stock Option (Right to Buy)
2025-06-17+21,850→ 21,850 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2025-06-04+33,662→ 33,662 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-06-18+16,000→ 16,000 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2024-06-05+23,114→ 23,114 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2023-06-29+48,128→ 48,128 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-06-15+12,000→ 12,000 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-06-06+16,532→ 16,532 total
Gift
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-09-20−1,500→ 28,528 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2022-09-01+10,391→ 10,391 total
Award
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2022-07-11+614,013→ 614,013 total
Award
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2022-07-11+614,013→ 614,013 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-06-21+4,975→ 4,975 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2022-06-21+29,307→ 29,307 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-05-20−1,585→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-05-20+1,585→ 30,028 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-01-18+24,000→ 24,000 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-22$190.50/sh−2→ 227,982 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-22$186.02/sh−319→ 227,663 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-22$189.13/sh−6,315→ 227,984 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-21+14,167→ 234,299 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$96.45/sh+1,036→ 215,801 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$119.13/sh+839→ 217,764 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−839→ 51,661 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$42.22/sh+2,368→ 220,132 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-12-10$88.95/sh+1,124→ 216,925 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−1,036→ 73,964 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−1,124→ 63,876 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-12-10−2,368→ 22,632 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$7.10/sh+33,978→ 248,743 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$170.36/sh−10,365→ 238,378 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$171.35/sh−7,742→ 230,636 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$172.22/sh−14,518→ 216,118 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$174.34/sh−670→ 214,765 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-11-12$173.25/sh−683→ 215,435 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-11-12−33,978→ 0 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2021-11-05+13,133→ 13,133 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2021-08-13$198.02/sh−2,441→ 246,303 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-08-13−33,979→ 33,978 total

Companies

Recent Filings

Address

75 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov